在癌症诊断和治疗中的CRISPR应用
Mingxia Wang1,2, Menghui Chen1, Xia Wu1
1Department of Dermatology, Skin Research Institute of Peking University Shenzhen Hospital, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Cellular & molecular biology letters
|September 6, 2023
概括
包括Cas9,Cas12和Cas13在内的集群定期间隔的短平行体重复 (CRISPR) 系统,为癌症治疗和诊断提供精确的基因编辑. 了解它们的功能和局限性是促进癌症治疗和分子诊断的关键.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 癌症是全球主要的健康问题,需要创新的治疗方法.
- 克里斯普尔基因编辑系统提供了新的治疗和诊断潜力.
- 像Cas9,Cas12和Cas13这样的CRISPR相关 (Cas) 蛋白质是这些进步的关键.
研究的目的:
- 审查Cas9,Cas12和Cas13的功能特性.
- 突出CRISPR在癌症基因治疗和分子诊断中的应用.
- 强调了解CRISPR系统的优势和局限性的重要性.
主要方法:
- 审查CRISPR-Cas系统 (Cas9,Cas12,Cas13) 和他们的活动.
- 对基于CRISPR的癌症基因疗法的当前进展进行分析.
- 探索CRISPR在癌症分子诊断中的应用.
主要成果:
- Cas9,Cas12和Cas13蛋白质表现出明显的分裂活动 (cis和trans).
- 在癌症基因治疗和分子诊断方面,CRISPR系统显著有前途.
- 了解系统特异性对于临床实用性至关重要.
结论:
- 克里斯普技术,特别是Cas9,Cas12和Cas13,正在彻底改变癌症研究.
- 预计CRISPR应用在癌症治疗和诊断方面的进一步创新.
- 本综述提供了一个全面的概述,以指导未来的研发.
关键词:
癌症 癌症 癌症 癌症在Cas12中,Cas12是Cas12中的一个.在Cas13中,Cas13是Cas13中的一个.这就是Cas9的情况.临床试验中的临床试验.诊断工具 诊断工具 诊断工具基因治疗是一种基因疗法.更多相关视频
相关概念视频
CRISPR
52.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.2K
CRISPR/Cas9 Genome Editing
48
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
48
CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K
The Antiviral System of Bacteria and Archaea: CRISPR
52
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
52


